The medical markets inthe Asia/Pacific region show enormous variations in size, due to differences in healthcare expenditure as well as the obvious differing population sizes. Although China and India have vastly greater populations than other countries in the region, it is the Japanese ablation market that takes the largest share of the global market, [...]
Below is a recent MedMarket Diligence report on Ablation Technologies. The report is described in detail at link.
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities
· 264 pages · 70 Exhibits · 61 Company Profiles · September 2008 · Report #A125
This report is a [...]
The major national markets in Western Europe for ablation technologies account for almost 12% of the global ablation market. Their share of the total medical device market is around 30%. Healthcare spending per capita is broadly similar across all the countries for which an example forecast (France) is provided below, ranging from approximately [...]
The energy-based medical device industry is led by a diverse group of companies, including small-to-medium pure-play companies specializing in ablation therapies and large multinationals whose interests encompass other classes of medical devices as well as ablation products. Key companies include Medtronic, St. Jude Medical, Varian Medical Systems, Boston Scientific (including Guidant), and Getinge.
In terms of [...]
From Report #A125, “Ablation Technologies Worldwide, 2008-2017″, published September 2008. See link.
Below are selected radiofrequency ablation products, their applications and their status of regulatory approval.
[Table=11]
For additional information on Report #A125, see link. The report may be purchased online or via Google Checkout, below.
USD3,450.00 - Worldwide Ablation Technologies, 2008-2017 (PDF) USD3,450.00 - Worldwide [...]
The worldwide high energy therapies market represents a $25 billion opportunity in 2008. The category consists of therapeutic devices and equipment that deliver the controlled application of one or more modalities of energy to tissue.
This market will grow at a compound annual growth rate of 11% with some modalities exceeding a 20% CAGR.
The global market [...]
